Protective effect of raloxifene on lipopolysaccharide and acid- induced acute lung injury in rats

Acta Pharmacologica Sinica

Volumn 28, Issue 10, 2007, Pages 1585-1590

  Zhou, Guang Ju ^a   Zhang, Hong ^a   Zhi, Sheng De ^b   Jiang, Guo Ping ^a   Wang, Jing ^a   Zhang, Mao ^a   Gan, Jian Xin ^a   Xu, Shao Wen ^a   Jiang, Guan Yu ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

Acute lung injury; Aspiration; Fluorodeoxyglucose; Lipopolysaccharide; microPET; Pulmonary edema; Raloxifene

Indexed keywords

CHLORIDE; FLUORODEOXYGLUCOSE F 18; HYDROCHLORIC ACID; LIPOPOLYSACCHARIDE; PLACEBO; RALOXIFENE;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GAS ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMORAL ARTERY; HISTOPATHOLOGY; INJURY SCALE; LUNG GAS EXCHANGE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PH MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; RAT; STATISTICAL ANALYSIS; THORACIC CAVITY;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; FLUORODEOXYGLUCOSE F18; HYDROCHLORIC ACID; HYDROGEN-ION CONCENTRATION; INJECTIONS; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; LUNG; MALE; POSITRON-EMISSION TOMOGRAPHY; PROTECTIVE AGENTS; RALOXIFENE; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY DISTRESS SYNDROME, ADULT; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TRACHEA;

EID: 34848813145     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00637.x     Document Type: Article

References (36)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967 2 : 319 23.
2. Isik AF, Kati I, Bayram I, Ozbek H. A new agent for treatment of acute respiratory distress syndrome: thymoquinone. An experimental study in a rat model. Eur J Cardiothorac Surg 2005 28 : 301 5.
3. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000 342 : 1301 8.
4. Jain R, DalNogare A. Pharmacological therapy for acute respiratory distress syndrome. Mayo Clin Proc 2006 81 : 205 12.
5. Jeyaseelan S, Chu H W, Young SK, Freeman MW, Worthen GS. Distinct roles of pattern recognition receptors CD14 and Tolllike receptor 4 in acute lung injury. Infect Immun 2005 73 : 1754 63.
6. Piantadosi CA, Schwartz DA. The acute respiratory distress syndrome. Ann Intern Med 2004 141 : 460 70.
7. Lang JD, Hickman-Davis JM. One-hit, two-hit....is there really any benefit Clin Exp Immunol 2005 141 : 211 4.
8. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000 342 : 1334 49.
9. Welty-Wolf KE, Carraway MS, Miller DL, Ortel TL, Ezban M, Ghio AJ, et al. Coagulation blockade prevents sepsis-induced respiratory and renal failure in baboons. Am J Respir Crit Care Med 2001 164 : 1988 96.
10. Fan J, Kapus A, Li YH, Rizoli S, Marshall JC, Rotstein OD. Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor. Am J Respir Cell Mol Biol 2000 22 : 412 21.
11. Fan J, Kapus A, Marsden PA, Li YH, Oreopoulos G, Marshall JC, et al. Regulation of Toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide. J Immunol 2002 168 : 5252 9.
12. Matthay MA, Zimmerman GA, Esmon C, Bhattacharya J, Coller B, Doerschuk CM, et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2003 167 : 1027 35.
13. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999 282 : 637 45.
14. Viereck V, Grundker C, Blaschke S, Niederkleine B, Siggelkow H, Frosch KH, et al. Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts. J Clin Endocrinol Metab 2003 88 : 4206 13.
15. Suuronen T, Nuutinen T, Huuskonen J, Ojala J, Thornell A, Salminen A. Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells. Inflamm Res 2005 54 : 194 203.
16. Esposito E, Iacono A, Raso GM, Pacilio M, Coppola A, Di Carlo R, et al. Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats. Endocrinology 2005 146 : 3301 8.
17. Speyer CL, Rancilio NJ, McClintock SD, Crawford JD, Gao H, Sarma JV, et al. Regulatory effects of estrogen on acute lung inflammation in mice. Am J Physiol Cell Physiol 2005 288 : C881 90.
18. Yu H P, Hsieh YC, Suzuki T, Shimizu T, Choudhry MA, Schwacha MG, et al. Salutary effects of estrogen receptor- Modulators. agonist on lung injury after trauma-hemorrhage. Am J Physiol Lung Cell Mol Physiol 2006 290 : L1004 9.
19. Lu KW, William Taeusch H, Robertson B, Goerke J, Clements JA. Polymer-surfactant treatment of meconium-induced acute lung injury. Am J Respir Crit Care Med 2000 162 : 623 8.
20. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 2003 34 : 2964 9.
21. Cepkova M, Matthay MA. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med 2006 21 : 119 43.
22. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003 4 (Suppl 31 S195 9.
23. Weinacker AB, Vaszar LT. Acute respiratory distress syndrome: physiology and new management strategies. Annu Rev Med 2001 52 : 221 37.
24. Nemzek JA, Call DR, Ebong SJ, Newcomb DE, Bolgos GL, Remick DG. Immunopathology of a two-hit murine model of acid aspiration lung injury. Am J Physiol Lung Cell Mol Physiol 2000 278 : L512 20.
25. Goldman G, Welbourn R, Klausner JM, Kobzik L, Valeri CR, Shepro D, et al. Leukocytes mediate acid aspiration-induced multiorgan edema. Surgery 1993 114 : 13 20.
26. 18F]fluorodeoxyglucose to evaluate neutrophil kinetics during acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004 286 : L834 40.
27. Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics 2005 25 : 1357 68.
28. 18F-FDG-labeled leukocytes. Q J Nucl Med Mol Imaging 2006 50 : 143 6.
29. Vos FJ, Bleeker-Rovers CP, Corstens FH, Kullberg BJ, Oyen WJ. FDG-PET for imaging of non-osseous infection and inflammation. Q J Nucl Med Mol Imaging 2006 50 : 121 30.
30. Jacene HA, Cohade C, Wahl RL. F-18 FDG PET/CT in acute respiratory distress syndrome: a case report. Clin Nucl Med 2004 29 : 786 8.
31. Velazquez M, Weibel ER, Kuhn CD, Schuster DP. PET evaluation of pulmonary vascular permeability: a structure-function correlation. J Appl Physiol 1991 70 : 2206 16.
32. Schuster DP, Stark T, Stephenson J, Royal H. Detecting lung injury in patients with pulmonary edema. Intensive Care Med 2002 28 : 1246 53.
33. Saxton JM, Pockley AG. Effect of ex vivo storage on human peripheral blood neutrophil expression of CD11b and the stabilizing effects of Cyto-Chex. J Immunol Methods 1998 214 : 11 7.
34. Shang Y, Brown M. Molecular determinants for the tissue specificity of SERMs. Science 2002 295 : 2465 8.
35. Olivier S, Close P, Castermans E, de Leval L, Tabruyn S, Chariot A, et al. Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature. Mol Pharmacol 2006 69 : 1615 23.
36. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 1997 82 : 4258 65.